Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

Author:  ["Awen Gallimore","Martin Cranage","Nicola Cook","Neil Almond","Janet Bootman","Erling Ruo","Pete Silvera","Michael Dennis","Terry Corcoran","Jim Stott","Andrew Mcmichael","Frances Gotch"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

In order to develop a successful subunit vaccine against infection with the human immunodeficiency virus (HIV), protective immune effector functions must be identified. Until now, there has been only indirect evidence that HIV-specific cytotoxic T lymphocytes (CTLs) fulfill this role. Using the macaque simian immunodeficiency virus (SIV) model, the protective potential of nef-specific CTLs, stimulated by vaccination, was examined in animals challenged with a high intravenous dose of the pathogenic simian immunodeficiency virus, SIVmac251(32H)(pJ5). An inverse correlation was found between the vaccine-induced nef-specific CTL precursor frequency and virus load measured after challenge. In addition, the early decline in viraemia, observed in both vaccinated and unvaccinated control animals was associated with the development of virus-specific CTL activity and not with the presence of virus-specific neutralizing antibodies. The results imply that vaccines that stimulate strong CTL responses could protect against HIV infection.

Cite this article

Gallimore, A., Cranage, M., Cook, N. et al. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med 1, 1167–1173 (1995). https://doi.org/10.1038/nm1195-1167

View full text

>> Full Text:   Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

Measurement of glucose in diabetic subjects using noninvasive transdermal extraction

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia